Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis

British Journal of Dermatology

Volumn 150, Issue 6, 2004, Pages 1174-1181

  Kyllonen H ^a   Remitz, A ^a   Mandelin, J M ^a   Elg, P ^a   Reitamo, S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Atopic dermatitis; Collagen synthesis; Skin atrophy; Skin thickness; Tacrolimus ointment; Topical corticosteroids

Indexed keywords

CORTICOSTEROID; PROCOLLAGEN; STEROID; TACROLIMUS;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL TRIAL; COLLAGEN SYNTHESIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MONOTHERAPY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SKIN ATROPHY; SKINFOLD THICKNESS; ULTRASOUND;

ADMINISTRATION, TOPICAL; ADULT; CASE-CONTROL STUDIES; COLLAGEN; COLLAGEN TYPE I; COLLAGEN TYPE III; DERMATITIS, ATOPIC; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SKIN; STATISTICS, NONPARAMETRIC; TACROLIMUS;

EID: 3142692443     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06017.x     Document Type: Article

References (43)

1. Prockop DJ, Kivirikko KI, Tudermann L, Gutzman NA. The biosynthesis of Collagen and its disorders, part one and two. N Engl J Med 1979; 301: 77-85.
2. Melkko J, Niemi S, Risteli L, Risteli J. Radioimmunoassay of the carboxyterminal propetide of human type I procollagen. Clin Chem 1990; 36: 1328-32.
3. Risteli J, Niemi S, Trivedi P et al. Rapid equilibrium radioimmunoassay for the aminoterminal propeptide of human type III procollagen. Clin Chem 1988; 34: 715-18.
4. Oikarinen A, Autio P, Kiistala U et al. A new method to measure type I and type III collagen synthesis in human skin in vivo: demonstration of decreased collagen synthesis after topical glucocorticosteroid treatment. J Invest Dermatol 1992; 98: 220-5.
5. Sarnstrand B, Brattsand R, Malmstrom A. Effect of glucocorticoids on glycosaminoglycan metabolism in cultured human skin fibroblasts. J Invest Dermatol 1982; 79: 412-17.
6. Reitamo S, Remitz A, Kyllönen H et al. Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis. Am J Clin Dermatol 2002; 3: 381-6.
7. Reitamo S, Wollenberg A, Schöpf E et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol 2000; 136: 999-1006.
8. Kang S, Lucky AW, Pariser D et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 2001; 44 (Suppl. 1): S58-64.
9. Reitamo S, Rissanen J, Remitz A et al. Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol 1998; 111: 396-8.
10. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; 92 (Suppl.): 22-47.
11. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol (Stockh) 1989; 144 (Suppl.): 13-14.
12. Reitamo S, Rustin M, Ruzicka T et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 2002; 109: 547-55.
13. Kiistala U. Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol 1968; 50: 129-37.
14. Tan CY, Statham B, Marks R, Payne PA. Skin thickness measurement by pulsed ultrasound: its reproducibility, validation and variability. Br J Dermatol 1982; 106: 657-67.
15. Haapasaari KM, Risteli J, Koivukangas V, Oikarinen A. Comparison of the effect of hydrocortisone, hydrocortisone-17-butyrate and betamethasone on collagen synthesis in human skin in vivo. Acta Derm Venereol (Stockh) 1995; 75: 269-71.
16. Agner T. Susceptibility of atopic dermatitis patients to irritant dermatitis caused by sodium lauryl sulphate. Acta Derm Venereol (Stockh) 1991; 71: 296-300.
17. Serup J. Characterization of contact dermatitis and atopy using bioengineering techniques. A survey. Acta Derm Venereol (Stockh) 1992; 177 (Suppl.): 14-25.
18. Seidenari S, Pagnoni A, Di Nardo A, Giannetti A. Echographic evaluation with image analysis of normal skin: variations according to age and sex. Skin Pharmacol 1994; 7: 201-9.
19. Gniadecka M, Serup J, Sondergaard J. Age-related diurnal changes of dermal oedema: evaluation by high-frequency ultrasound. Br J Dermatol 1994; 131: 849-55.
20. Eisenbeiss C, Welzel J, Schmeller W. The influence of female sex hormones on skin thickness: evaluation using 20 MHz sonography. Br J Dermatol 1998; 139: 462-7.
21. Eisenbeiss C, Welzel J, Eichler W, Klotz K. Influence of body water distribution on skin thickness: measurements using high-frequency ultrasound. Br J Dermatol 2001; 144: 947-51.
22. Haapasaari KM, Risteli J, Oikarinen A. Recovery of human skin collagen synthesis after short-term topical corticosteroid treatment and comparison between young and old subjects. Br J Dermatol 1996; 135: 65-9.
23. Autio P, Karjalainen J, Risteli L et al. Effects of an inhaled steroid (budesonide) on skin collagen synthesis of asthma patients in vivo. Am J Respir Crit Care Med 1996; 153: 1172-5.
24. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995; 270: 283-6.
25. Hughes J, Rustin M. Corticosteroids. Clin Dermatol 1997; 15: 715-21.
26. Dumont FJ. FK 506, an immunosuppressant targeting calcineurin function. Curr Med Chem 2000; 7: 731-48.
27. Khanna A, Cairns V, Hosenpud JD. Tacrolimus induces increased expression of transforming growth factor-β1 in mammalian lymphoid as well as nonlymphoid cells. Transplantation 1999; 67: 614-19.
28. Wang T, Li BY, Danielson PD et al. The immunophilin FKBP12 functions as a common inhibitor of the TGF-beta family type I receptors. Cell 1996; 86: 435-44.
29. Okadome T, Oeda E, Saitoh M et al. Characterization of the interaction of FKBP12 with the transforming growth factor-beta type I receptor in vivo. J Biol Chem 1996; 271: 21687-90.
30. 3 human skin collagen. Release by pepsin digestion and preponderance in fetal life. J Biol Chem 1974; 249: 3225-31.
31. Grahan M, Diegelmann R, Lindblad W et al. Effects of inflammation on wound healing: in vitro studies and in vivo studies. In: Soft and Hard Tissue Repair: Biological and Clinical Aspects (Hunt T, Heppenstall R, Pines E, Rovee D, eds). New York: Praeger Scientific, 1984; 361-79.
32. Nimni ME. Collagen: structures, function, and metabolism in normal and fibrotic tissues. Semin Arthritis Rheum 1983; 13: 1-86.
33. Rasmussen LH, Jensen LT, Avnstorp C et al. Collagen types I and III propeptides as markers of healing in chronic leg ulcers. A noninvasive method for the determination of procollagen propeptides in wound fluid - influence of growth hormone. Ann Surg 1992; 216: 684-91.
34. Eriksen HA, Pajala A, Leppilahti J, Risteli J. Increased content of type III collagen at the rupture site of human Achilles tendon. J Orthop Res 2002; 20: 1352-7.
35. Cheung DT, DiCesare P, Benya PD et al. The presence of intermolecular disulfide cross-links in type III collagen. J Biol Chem 1983; 258: 7774-8.
36. Liu SH, Yang R, Al-Shaikh R, Lane JM. Collagen in tendon, ligament, and bone healing. A current review. Clin Orthop 1995; 318: 265-78.
37. Mempel M, Schmidt T, Boeck K et al. Changes in collagen I and collagen III metabolism in patients with generalized atopic eczema undergoing medium-dose ultraviolet A1 phototherapy. Br J Dermatol 2000; 142: 473-80.
38. Autio P, Risteli J, Haukipuro K et al. Collagen synthesis in human skin in vivo', modulation by aging, ultraviolet B irradiation and localization. Photodermatol Photoimmunol Photomed 1994; 10: 212-16.
39. Boguniewicz M, Fiedler VC, Raimer S et al. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. J Allergy Clin Immunol 1998; 102: 637-44.
40. Reitamo S, van Leent EJ, Ho V et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 2002; 109: 539-46.
41. Paller A, Eichenfield LF, Leung DY et al. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol 2001; 44 (Suppl. 1): S47-57.
42. Hanifin JM, Ling MR, Langley R et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy. J Am Acad Dermatol 2001; 44 (Suppl. 1): S28-38.
43. Ruzicka T, Bieber T, Schöpf E et al. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 1997; 337: 816-21.